Comparing mesh repair to standard surgery for large hiatal hernias
Onlay Synthetic Bioabsorbable Mesh Herniorrhaphy Versus Herniorrhaphy Only in the Primary Treatment of Large Hiatal Hernia: a Multicenter, Randomized, Parallel-group, Evaluator Blinded, Phase III Clinical Trial
This study is testing if using a special mesh during surgery for large hiatal hernias helps prevent them from coming back compared to regular stitching, and it's for adults who have symptoms from these hernias.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 256 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Bordeaux Academic / other |
| Locations | 26 sites (Bayonne and 25 other locations) |
| Trial ID | NCT05867225 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of using a biosynthetic absorbable mesh in laparoscopic repair of large hiatal hernias compared to standard suture repair without mesh. The study will assess the radiologic recurrence rate of hernias at two years post-surgery, as well as the improvement of specific symptoms in patients. Participants will be adults with symptomatic large hiatal hernias, defined as those larger than 5 cm, and will undergo a standardized surgical approach. The trial seeks to determine if the addition of mesh can reduce the rate of recurrence without increasing complications.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with symptomatic large hiatal hernias.
Not a fit: Patients with asymptomatic hiatal hernias or those requiring reoperation for recurrent hernias may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the recurrence of large hiatal hernias and improve patient outcomes.
How similar studies have performed: While there is limited comparative effectiveness data available, previous studies have suggested that mesh reinforcement may help prevent recurrence, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient undergoing laparoscopic primary repair for symptomatic LHH. LHH is defined as a hiatal hernia larger than 5 cm in axial length as diagnosed at barium series and/or CT-scan with contrast swallow and/or CT-scan with contrast injection with axial reconstruction. * Symptomatic hiatal hernia: heartburn and/or regurgitation and/or epigastric pain and/or dysphagia and/or anemia (if exclusion of other origin); * Patient aged ≥ 18 years; * Patient affiliated to a social security system or beneficiary of the same; * Free written informed consent signed by the participant and the investigator (no later than the inclusion day and before performing any examination required for the study). Exclusion Criteria: * Patient undergoing reoperation for recurrent LHH repair; * Emergency presentation needing an operation in a delay \<6 hours; * Asymptomatic hiatal hernia; * American anesthesiologist score \>3; * Recurrent hiatal hernia and previous surgical interventions involving gastroesophageal junction; * Brachyesophagus defined as the impossibility to achieve an intraabdominal length of the esophagus of at least 3cm after reduction of hernia contents and complete dissection and resection of the hernia sac; * Previous major upper gastrointestinal surgery; * Inability to perform primary closure of the crura; * Pregnant or breast-feeding woman; * Persons deprived of liberty or under guardianship or incapable of giving consent; * Any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol or follow-up schedule, as assessed by investigator.
Where this trial is running
Bayonne and 25 other locations
- CH de la Côte Basque — Bayonne, France (Not_yet_recruiting)
- Hôpital Jean Minjoz, CHRU de Besançon — Besançon, France (Not_yet_recruiting)
- Hôpital Cavale blanche, CHRU de Brest — Brest, France (Not_yet_recruiting)
- Hôpital Côte de nacre, CHU Caen Normandie — Caen, France (Not_yet_recruiting)
- Hôpital Estang — Clermont-Ferrand, France (Not_yet_recruiting)
- Hôpital Louis-Mourier, AP-HP — Colombes, France (Not_yet_recruiting)
- Hôpital Nord, CHU de Grenoble — La Tronche, France (Not_yet_recruiting)
- Hôpital Claude Huriez, CHRU de Lille — Lille, France (Not_yet_recruiting)
- Polyclinique du bois, Hôpital privé Le Bois — Lille, France (Not_yet_recruiting)
- Hôpital Dupuytren 1, CHU de Limoges — Limoges, France (Not_yet_recruiting)
- Hôpital de la Croix-Rousse, HCL — Lyon, France (Not_yet_recruiting)
- Hôpital Saint Eloi, CHU de Montpellier — Montpellier, France (Not_yet_recruiting)
- Hôpital Hôtel Dieu, CHU de Nantes — Nantes, France (Not_yet_recruiting)
- Hôpital Archet, CHU de Nice — Nice, France (Not_yet_recruiting)
- Hôpital Saint-Louis, AP-HP — Paris, France (Not_yet_recruiting)
- Hôpital Saint-Antoine, AP-HP — Paris, France (Not_yet_recruiting)
- DMU SAPERE, CHU Pitié-Salpêtrière APHP — Paris, France (Not_yet_recruiting)
- Institut Mutualiste Montsouris — Paris, France (Not_yet_recruiting)
- Hôpital Bichat, AP-HP — Paris, France (Not_yet_recruiting)
- Hôpital du Haut Lévêque — Pessac, France (Recruiting)
- Hôpital Jean-Bernard, CHU de Poitiers — Poitiers, France (Not_yet_recruiting)
- CH René-Dubos — Pontoise, France (Recruiting)
- CHU de Rennes, Site PONTCHAILLOU — Rennes, France (Not_yet_recruiting)
- Hôpital Charles Nicolle, CHU de Rouen — Rouen, France (Not_yet_recruiting)
- Hôpital Felix-Guyon, CHU de la Réunion — Saint-Paul, France (Not_yet_recruiting)
- Hôpital Rangueil, CHU de Toulouse — Toulouse, France (Not_yet_recruiting)
Study contacts
- Principal investigator: Caroline Gronnier, MD, PhD — University Hospital, Bordeaux
- Study coordinator: Caroline Gronnier, MD, PhD
- Email: caroline.gronnier@chu-bordeaux.fr
- Phone: + 33 5 57 65 60 05
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.